| Title |
Theranostics in nuclear medicine practice
|
|---|---|
| Published in |
OncoTargets and therapy, October 2017
|
| DOI | 10.2147/ott.s140671 |
| Pubmed ID | |
| Authors |
Anna Yordanova, Elisabeth Eppard, Stefan Kürpig, Ralph A Bundschuh, Stefan Schönberger, Maria Gonzalez-Carmona, Georg Feldmann, Hojjat Ahmadzadehfar, Markus Essler |
| Abstract |
The importance of personalized medicine has been growing, mainly due to a more urgent need to avoid unnecessary and expensive treatments. In nuclear medicine, the theranostic approach is an established tool for specific molecular targeting, both for diagnostics and therapy. The visualization of potential targets can help predict if a patient will benefit from a particular treatment. Thanks to the quick development of radiopharmaceuticals and diagnostic techniques, the use of theranostic agents has been continually increasing. In this article, important milestones of nuclear therapies and diagnostics in the context of theranostics are highlighted. It begins with a well-known radioiodine therapy in patients with thyroid cancer and then progresses through various approaches for the treatment of advanced cancer with targeted therapies. The aim of this review was to provide a summary of background knowledge and current applications, and to identify the advantages of targeted therapies and imaging in nuclear medicine practices. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Saudi Arabia | 2 | 29% |
| United States | 2 | 29% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 86% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 275 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 275 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 32 | 12% |
| Student > Bachelor | 32 | 12% |
| Student > Master | 28 | 10% |
| Researcher | 27 | 10% |
| Other | 16 | 6% |
| Other | 49 | 18% |
| Unknown | 91 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 16% |
| Chemistry | 29 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 8% |
| Physics and Astronomy | 18 | 7% |
| Biochemistry, Genetics and Molecular Biology | 11 | 4% |
| Other | 48 | 17% |
| Unknown | 102 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2019.
All research outputs
#4,806,959
of 25,604,262 outputs
Outputs from OncoTargets and therapy
#210
of 3,012 outputs
Outputs of similar age
#78,156
of 331,843 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 77 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,012 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,843 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.